Dublin, Nov. 05, 2018 (GLOBE NEWSWIRE) -- The "Global Post-Herpetic Neuralgia Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Global Post-Herpetic Neuralgia Market and Competitive Landscape - 2018, provides comprehensive insights into Post-Herpetic Neuralgia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Post-Herpetic Neuralgia market size and drug sales. This research also provides insights into Post-Herpetic Neuralgia epidemiology and late stage pipeline.

The research is classified into following sections - Post-Herpetic Neuralgia overview with definitions, symptoms, etiology, diagnosis, treatment options; Post-Herpetic Neuralgia pipeline insights covering late stage clinical trials pipeline; Post-Herpetic Neuralgia prevalence trends by countries; Post-Herpetic Neuralgia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

• Post-Herpetic Neuralgia pipeline: Find out the drugs in clinical trials for Post-Herpetic Neuralgia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Post-Herpetic Neuralgia epidemiology: Find out the prevalence of Post-Herpetic Neuralgia by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
• Post-Herpetic Neuralgia products: Identify key products marketed and prescribed for Post-Herpetic Neuralgia by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
• Post-Herpetic Neuralgia market size: Find out the market size for Post-Herpetic Neuralgia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
• Post-Herpetic Neuralgia drug sales: Find out the sales of Post-Herpetic Neuralgia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
• Post-Herpetic Neuralgia drugs sales forecast: Sales forecast for Post-Herpetic Neuralgia drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
• Post-Herpetic Neuralgia market share analysis: Find out the market shares of Post-Herpetic Neuralgia drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

• Evaluate commercial market opportunities for Post-Herpetic Neuralgia drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Post-Herpetic Neuralgia market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Post-Herpetic Neuralgia market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Post-Herpetic Neuralgia: Disease Overview

2. Post-Herpetic Neuralgia Pipeline Insights

3. Post-Herpetic Neuralgia Epidemiology Analysis

4. US Post-Herpetic Neuralgia Market Insights

5. Germany Post-Herpetic Neuralgia Market Insights

6. France Post-Herpetic Neuralgia Market Insights

7. Italy Post-Herpetic Neuralgia Market Insights

8. Spain Post-Herpetic Neuralgia Market Insights

9. UK Post-Herpetic Neuralgia Market Insights

10. Europe Post-Herpetic Neuralgia Market Insights

11. Japan Post-Herpetic Neuralgia Market Insights

12. Global Post-Herpetic Neuralgia Market Insights

13. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/rb3b7h/global?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs